As a genetic risk factor of AD, FERMT2 was identified to be implicated in amyloid precursor protein (APP) metabolism and downregulated FERMT2 promoted Aβ peptide production through facilitating the mature APP recycling and elevating its levels at the cell surface [20]. The gene discussed is APP; the disease is Alzheimer disease.